Treatment of Influenza in a Pregnant Patient
Influenza in pregnancy requires careful clinical attention. Antiviral therapy decisions in this setting are shaped by safety considerations specific to pregnancy, making drug selection distinct from the general adult population.
Clinical Scenario
A pregnant patient presenting with confirmed or suspected influenza. Pregnancy status directly influences which antiviral agents are appropriate and which should be avoided.
Treatment Approach
Antiviral treatment is recommended, with a specific oral agent identified as preferred during pregnancy. Not all antivirals used in non-pregnant adults are appropriate here — certain agents are not recommended due to absent safety and efficacy data in pregnancy. The full regimen, including drug selection rationale, is in the protocol.
Clinical Goals
The aims of treatment are shortening the duration of fever and influenza illness symptoms, and achieving resolution of fever and symptoms.
References
DOI: 10.1093/cid/ciy866
Oral oseltamivir is the preferred treatment during pregnancy.
The same antiviral dosing is recommended during pregnancy as for those who are not pregnant.
Baloxavir is not recommended for the treatment of influenza during pregnancy or while breastfeeding, as there are no available efficacy or safety data for baloxavir in pregnancy, and no available data on the presence of baloxavir in human milk, the effects on the breastfed infant, or the effects on milk production.
View source ↗